Millipore Sigma Vibrant Logo

AB10605 Anti-ANGPTL4 (MID) Antibody

View Products on Sigmaaldrich.com
AB10605
100 µg  
正在检索价格......
无法检索价格。
最小订购数量为倍数
Maximum Quantity is
以订单确认为准 更多信息
您节约了 ()。
 
Request Pricing
目前缺货
目前缺货
有货 
停产
少量现货
供货情况有待确认
    其余:另行通知
      其余:另行通知
      另行通知
      联系客户服务
      Contact Customer Service

      特卖

       

      联系客户服务

      概述

      Replacement Information

      重要规格表

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      H, M, RWBRbPurifiedPolyclonal Antibody
      Description
      Catalogue NumberAB10605
      Brand Family Chemicon®
      Trade Name
      • Chemicon
      DescriptionAnti-ANGPTL4 (MID) Antibody
      Background InformationANGPTL4 (angiopoietin-like protein 4, hepatic fibrinogen/angiopoietin-related protein (HFARP), fasting-induced adipose factor (FIAF), PPARγ angiopoietin-related protein (PGAR)) is a secreted protein selectively expressed in adipose tissue, liver, and placent, that plays a variety of roles in vivo, ranging from adipogenesis to angiogenesis to carcinogenesis. Several transcription factors exert influence on ANGPTL4 transcription, including PPARα, PPARγ, and HIF 1α. PPARα and HIF 1α synergistically cause the activation of ANGPTL4 in cardiomyocytes; induction of ANGPTL4 in the heart inhibits lipoprotein-derived fatty acid delivery. As a transcriptional target of PPARγ, ANGPTL4 has been hypothesized to play a role in adipogenesis, insulin sensitivity, and energy metabolism. The expression of ANGPTL4 is also under nutritional and hormonal control. During fasting conditions, transcription of ANGPTL4 in both liver and adipose tissue is induced independently of PPARα1 While circulating levels of ANGPTL4 are increased in genetically obese mice, rodents fed a highfat diet demonstrate reduced circulating ANGPTL4 levels, suggesting that ANGPTL4 may be involved in response to the availability of nutrients. In endothelial cells, ANGPTL4 mRNA and protein levels increase in response to hypoxia. ANGPTL4 has been observed to induce a strong pro-angiogenic response independent of vascular endothelial growth factor (VEGF), and its expression has been described in hypoxic human tissues as well as a variety of cancers, including liposarcoma, hepatocellular carcinoma, and conventional renal cell carcinoma. Taken together, these findings suggest that ANGPTL4 may be involved in the mechanisms that compensate for ischemia by angiogenesis.
      References
      Product Information
      FormatPurified
      Presentation400 μL aliquot at a concentration of 0.25 mg/mL in phosphate buffered saline (pH 7.4) containing 0.1% sodium azide.
      Quality LevelMQ100
      Applications
      ApplicationAnti-ANGPTL4 (MID) Antibody is an antibody against ANGPTL4 (MID) for use in WB.
      Key Applications
      • Western Blotting
      Application NotesWestern Blotting: 1-3 μg/mL
      Biological Information
      ImmunogenSynthetic peptide derived from an internal region of the human ANGTPL4 protein, which differs from rat and mouse by one and two conservative amino acid replacements, respectively.
      CloneZMD.521
      HostRabbit
      SpecificityRecognizes ANGPTL4 (MID).
      Species Reactivity
      • Human
      • Mouse
      • Rat
      Species Reactivity NoteHuman, Mouse, Rat (positive controls: HepG2 and NGP96 cell lysates, mouse placenta and rat liver homogenates, serum-stimulated mouse 3T3-L1 embryo fibroblast lysates, and 2 week-old mouse brain homogenates).
      Antibody TypePolyclonal Antibody
      Entrez Gene Number
      Entrez Gene SummaryThis gene is a member of the angiopoietin/angiopoietin-like gene family and encodes a glycosylated, secreted protein with a fibrinogen C-terminal domain. This gene is induced under hypoxic conditions in endothelial cells and is the target of peroxisome proliferation activators. The encoded protein is a serum hormone directly involved in regulating glucose homeostasis, lipid metabolism, and insulin sensitivity and also acts as an apoptosis survival factor for vascular endothelial cells. The encoded protein may play a role in several cancers and it also has been shown to prevent the metastatic process by inhibiting vascular activity as well as tumor cell motility and invasiveness. Decreased expression of this protein has been associated with type 2 diabetes. Alternatively spliced transcript variants encoding different isoforms have been described. This gene was previously referred to as ANGPTL2 but has been renamed ANGPTL4.
      Gene Symbol
      • ANGPTL4
      • UNQ171/PRO197
      • HFARP
      • ANGPTL2
      • PSEC0166
      • PGAR
      • NL2
      • pp1158
      • ARP4
      • FIAF
      Purification MethodImmunoAffinity Purified
      UniProt Number
      UniProt SummaryFUNCTION: SwissProt: Q9BY76 # Protein with hypoxia-induced expression in endothelial cells. May act as a regulator of angiogenesis and modulate tumorgenesis. Inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage. May exert a protective function on endothelial cells through an endocrine action. It is directly involved in regulating glucose homeostasis, lipid metabolism, and insulin sensitivity. In response to hypoxia, the unprocessed form of the protein accumulates in the subendothelial extracellular matrix (ECM). The matrix-associated and immobilized unprocessed form limits the formation of actin stress fibers and focal contacts in the adhering endothelial cells and inhibits their adhesion. It also decreases motility of endothelial cells and inhibits the sprouting and tube formation (By similarity).
      SIZE: 406 amino acids; 45214 Da
      SUBUNIT: Homooligomer. The homooligomer undergoes proteolytic processing to release its carboxyl fibrinogen-like domain, which circulates as a monomer. The homooligomer unprocessed form is able to interact with the extracellular matrix (By similarity).
      SUBCELLULAR LOCATION: Secreted. Secreted, extracellular space, extracellular matrix (By similarity). Note=The unprocessed form interacts with the extracellular matrix. This may constitute a dynamic reservoir, a regulatory mechanism of the bioavailability of ANGPTL4 (By similarity).TISSUE SPECIFICITY: Expressed at high levels in the placenta, heart, liver, muscle, pancreas and lung but expressed poorly in the brain and kidney.
      PTM: N-glycosylated.
      DISEASE: SwissProt: Q9BY76 # Found to be highly expressed in the early stages of collagen-induced arthritis (CIA). & Serum levels of ANGPTL4 are significantly lower in patients with diabetes type 2 than those in healthy subjects, suggesting that decreased ANGPTL4 could be a causative factor of this disease. & Produced in ischemic tissues in conditions such as critical leg ischemia. In tumors, ANGPTL4 could be produced in the hypoxic areas surrounding necrotic regions. High levels could be produced in tumor cells of conventional renal cell carcinoma. This molecule therefore seems to be a marker of conventional renal cell carcinoma.
      SIMILARITY: SwissProt: Q9BY76 ## Contains 1 fibrinogen C-terminal domain.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsMaintain at -20°C in undiluted aliquots for up to 12 months. Avoid repeated freeze/thaw cycles.
      Packaging Information
      Material Size100 µg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      产品目录编号 GTIN
      AB10605 04053252369650

      Documentation

      Anti-ANGPTL4 (MID) Antibody MSDS

      职位

      物料安全数据表 (MSDS) 

      Anti-ANGPTL4 (MID) Antibody 分析证书

      标题批号
      RABBIT ANTI-ANGPTL4 (MID) POLYCLONAL ANTIBODY - 2420384 2420384
      RABBIT ANTI-ANGPTL4 (MID) - 3603053 3603053
      RABBIT ANTI-ANGPTL4 (MID) - 3835232 3835232
      RABBIT ANTI-ANGPTL4 (MID) - 3939229 3939229
      RABBIT ANTI-ANGPTL4 (MID) - 3948179 3948179
      RABBIT ANTI-ANGPTL4 (MID) -2585885 2585885
      RABBIT ANTI-ANGPTL4 (MID) POLYCLONAL ANTIBODY 3089157
      RABBIT ANTI-ANGPTL4 (MID) POLYCLONAL ANTIBODY 3143234
      RABBIT ANTI-ANGPTL4 (MID) POLYCLONAL ANTIBODY - 2280825 2280825

      参考

      参考概述公共医疗ID
      Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene
      Kersten, S, et al
      J Biol Chem, 275:28488-93 (2000)  2000

      10862772 10862772
      Molecular cloning and functional expression of mouse connexin40, a second gap junction gene preferentially expressed in lung.
      Hennemann, H, et al.
      J. Cell Biol., 117: 1299-310 (1992)  1992

      显示摘要
      1318884 1318884

      数据表

      标题
      RABBIT ANTI-ANGPTL4 (MID) POLYCLONAL ANTIBODY